Clinical Research Study on Pediatric and Adolescent Depression is Now Enrolling Participants

January 04, 2017

Does your child have depression? If so, s/he may be eligible to participate in a new research study being conducted by Dr. Salma Malik testing the effects of Vilazodone for the treatment of Depression. Participants must be 7 to 17 years of age and generally healthy. Qualified participants will receive study-related care, health exams and medication at no cost. Financial compensation for time and travel may be provided. For more information contact the Clinical Trials Unit at 860.545.7502 or email at [email protected].